The Guardian
NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal
Agreement could cost NHS an extra £3bn a year, industry sources estimate The UK has agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal that will cost an estimated additional £3bn a year. The transatlantic agreement will also see the health service in England, which ...
4 hours ago